Menu
Search

News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

Curated Newsfeed

See all news

DTN Highlights

See DTN Highlights

  • Swiss start-up scene tops patent rankings

    The European Patent Office (EPO) has carried out a study to identify the universities from which start-ups use research results. Three Swiss universities made it…

    startupticker.ch

    • European universities' patent applications rose from 6% in 2000 to over 10% in 2019, with 12% filed by startups.
    • ETH Zurich, EPFL, and University of Zurich rank among Europe's top 12 universities for startup innovation.
    • Switzerland leads Europe with 74.2 deep tech startups per million inhabitants with patents, outpacing Sweden and UK.
    startupticker.ch: Swiss start-up scene tops patent rankings

  • Monte-Rosa Therapeutics enters billion-dollar partnership with Novartis

    Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced a global license agreement with Novartis. Under the terms…

    startupticker.ch

    • Novartis licensed Monte Rosa's VAV1-directed molecular glue degraders, paying $150M upfront plus up to $2.1B in milestones.
    • MRT-6160 is an oral drug showing promise in preclinical models for multiple sclerosis, rheumatoid arthritis, and IBD.
    • Monte Rosa co-funds Phase 3 development and shares U.S. profits; Novartis leads Phase 2 and global commercialization.
    startupticker.ch: Monte-Rosa Therapeutics enters billion-dollar partnership with Novartis

  • $10 million to make web3 data accessible

    Born global with a team spread across the globe, Validation Cloud is a leading Web3 data and AI company. Its staking product has more than…

    startupticker.ch

    • Validation Cloud raised $10M led by True Global Ventures to expand its AI product for Web3 data accessibility.
    • The company's staking product exceeded $1 billion in assets with 400% year-over-year growth.
    • Validation Cloud combines staking, node API, and AI to compress blockchain data exploration from hours to seconds.
    startupticker.ch: $10 million to make web3 data accessible

  • ONWARD Medical raises EUR 50 Million in an upsized capital increase

    ONWARD Medical successfully raised an amount of EUR 50 million in gross proceeds by way of an upsized bookbuild offering through a private placement with…

    startupticker.ch

    • ONWARD Medical raised EUR 50M via private placement for spinal cord injury therapies and ARC-EX system commercial launch.
    • Ottobock invested EUR 22.5M for ~10% stake and will explore strategic development and commercial partnerships.
    • Funds allocated: R&D (40%), U.S. ARC-EX launch (30%), operations (20%), strategic opportunities (10%).
    startupticker.ch: ONWARD Medical raises EUR 50 Million in an upsized capital increase

  • On the runway: Swiss Airtainer and Assaia onboard new customers

    Swiss Airtainer is collaborating with Delta Cargo, a US-based air freight service provider, to utilize its smart containers for the secure transport of pharmaceutical and…

    startupticker.ch

    • Delta Cargo became the first U.S. carrier to offer Swiss Airtainer's RKN smart containers with solar panels and AI sensors for pharmaceutical transport.
    • Assaia's ApronAI system at Rome's Fiumicino Airport uses video analytics to optimize aircraft turnarounds across 57 gates.
    • Swiss Airtainer's RKN container uses lightweight design and sensors for temperature control and traceability of shipments.
    startupticker.ch: On the runway: Swiss Airtainer and Assaia onboard new customers

  • Energy storage start-up terralayr raises CHF67 million

    Zug-based terralayr is a developer and owner-operator of battery storage assets in Germany, offering a unique “energy flexibility as a service” platform. The start-up has…

    startupticker.ch

    • Terralayr raised €62M equity and €15M debt, with RIVE as first infrastructure investor, accelerating German battery storage deployment.
    • Terralayr offers energy flexibility-as-a-service via cloud platform, letting customers access grid-scale battery benefits without ownership.
    • Terralayr secured 5GW+ battery storage development agreements, operates its first asset, targeting utilities, traders, and data centers.
    startupticker.ch: Energy storage start-up terralayr raises CHF67 million

  • CHF 2.8 million to improve eCommerce recommendations

    Swiss AI startup Albatross closed a €3 million (CHF 2.8 million) funding round led by redalpine, with participation from Daphni. Albatross AI-driven solutions generate engaging…

    startupticker.ch

    • Swiss AI startup Albatross raised €3M to build recommendation systems using deep learning and reinforcement learning for product personalization.
    • Albatross founders are former Amazon machine learning experts who developed recommendation platforms at scale.
    • The platform dynamically optimizes user experiences without invasive tracking, addressing limits of A/B testing and static personalization.
    startupticker.ch: CHF 2.8 million to improve eCommerce recommendations

  • French life sciences consultancy acquires IntiQuan

    IntiQuan AG, a Swiss consulting specializing in pharmacometric services, has been acquired by ProductLife Group, a French global leader in regulatory, scientific, compliance, and digital…

    startupticker.ch

    • ProductLife Group acquired IntiQuan AG, a Swiss pharmacometrics specialist, to expand drug development capabilities across its platform.
    • IntiQuan's expertise in pharmacokinetics and modeling helps reduce clinical development costs, timelines, and risks for PLG's 1000+ clients.
    • The acquisition strengthens PLG's strategy to become a leading global drug development provider with planned US and European expansions.
    startupticker.ch: French life sciences consultancy acquires IntiQuan

  • CHF 39 million for BE WTR eco-friendly premium water solutions

    BE WTR, the Swiss startup revolutionizing sustainable water solutions, just closed its CHF 39M Series C funding round. This new round of funding will accelerate BE…

    startupticker.ch

    • BE WTR closed a CHF 39M Series C round led by Convent Capital to expand sustainable water solutions globally.
    • The company operates compact on-site bottling plants in high-end venues, targeting over 20 locations by end-2025.
    • BE WTR offers water activation and circular bottling as a sustainable alternative to traditional bottled water.
    startupticker.ch: CHF 39 million for BE WTR eco-friendly premium water solutions

  • Lymphatica Medical raises €17.9 million in series B Funding

    Lymphatica Medtech SA is a clinical-stage company based in Lausanne, specialized in innovative treatments for lymphedema, a chronic vascular condition that currently has no cure…

    startupticker.ch

    • Lymphatica Medtech raised Series B funding to advance LymphoDrain, an implantable device for treating lymphedema.
    • LymphoDrain is minimally invasive, implanted subcutaneously, and actively restores lymphatic vessel function.
    • Dan Rose, former leader at LimFlow and Medtronic, joined as Chairman, strengthening the board.
    startupticker.ch: Lymphatica Medical raises €17.9 million in series B Funding

  • €36 million to digitalise farming with xFarm’s platform

    xFarm Technologies a Swiss-Italian startup dedicated to digitalising the agri-food sector, has raised €36 million in series C round. The funds will enable the company…

    startupticker.ch

    • xFarm supports 450,000+ farms across 100+ supply chains covering 7 million hectares using AI-powered data analysis and regenerative agriculture models.
    • xFarm is creating a new Fintech and Insurtech division to enhance insurance and financial management services for farmers.
    startupticker.ch: €36 million to digitalise farming with xFarm’s platform

  • CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial

    Somagenetix AG, a pioneering biotech company focussing on gene therapies for disorders affecting a type of white blood cells, raised CHF 10 million in a…

    startupticker.ch

    • Somagenetix AG raised CHF 10M in Series A funding for SGX-001, a gene therapy for p47 Chronic Granulomatous Disease, targeting 2026 clinical trials.
    • The company's lentiviral gene therapy platform offers a one-time treatment alternative to stem cell transplants for inherited immunodeficiencies.
    • Dr. Andrin Oswald joined as CEO, bringing over 20 years of pharmaceutical leadership experience to guide clinical development.
    startupticker.ch: CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial